Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Precision BioSciences

Precision BioSciences
2006 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
DTIL STOCK SYMBOL
$9.93 SHARE PRICE (As of Friday Closing)
Description

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 302 East Pettigrew Street
  • Dibrell Building, Suite A-100
  • Durham, NC 27701
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Precision BioSciences’s full profile, request a free trial.

Precision BioSciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$6.24 - $23.67 $504M $10.10 -$2.31 1.23M 50.8M

Precision BioSciences Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
Enterprise Value 198,695
Revenue 20,656 10,883 6,484
EBITDA (86,899) (45,558) (20,539)
Net Income (87,404) (46,037) (21,102)
Total Assets 260,298 138,600 72,682
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Precision BioSciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Precision BioSciences‘s full profile, request access.

Request full access to PitchBook

Precision BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Precision BioSciences‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Precision BioSciences Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Onxeo Formerly PE-Backed Paris, France 00 00000 00000000000 00000
000000 00000000000 Venture Capital-Backed San Diego, CA 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Richmond, CA 000 000.00 00000000 000.00
000000 00000000000 Formerly VC-backed Zug, Switzerland 000 00000 00000000000 00000
000000000000 Venture Capital-Backed Seattle, WA 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Precision BioSciences Executive Team (13)

Name Title Board
Seat
Contact
Info
Matthew Kane Chief Executive Officer & Founder
Abid Ansari Chief Financial Officer
David Thomson Ph.D Chief Operating Officer
Jeff Smith Ph.D Co-Founder & Chief Technology Officer
Derek Jantz Chief Scientific Officer & Founder

3 Former Executives

You’re viewing 5 of 13 executives. Get the full list »

Precision BioSciences Board Members (5)

Name Representing Role Since Contact
Info
Shalini Sharp Self Board Member 000 0000
Tony Yao Self Board Member 000 0000

3 Former Board Members

You’re viewing 2 of 5 board members. Get the full list »